Helbig’s Paradoxical Diagnosis
- YouTube pioneer and comedian Grace Helbig, 41, shared an emotional update one month after undergoing surgery to remove two brain tumors, revealing that her breast cancer has spread to her brain, making it stage 4 metastatic breast cancer.
- Despite the stage 4 diagnosis, Helbig says she currently has “no evidence of disease” (NED), meaning scans can’t detect any cancer in her body. She calls herself “the paradox of stage four metastatic breast cancer NED.”
- Helbig was first diagnosed with triple-positive breast cancer in 2023. Triple-positive breast cancer is fueled by the hormones estrogen and progesterone and by a protein called HER2, and HER2-positive breast cancer carries a higher risk of spreading to the brain.
- While stage 4 breast cancer can’t be cured, advances in treatment mean many patients now live with it for years, managing it much like a chronic illness.
- Check out SurvivorNet’s doctor‑supported platform, “My Health Questions,” an AI-powered tool for clarity and support.
In a recent video, shared one month after surgery to remove two brain tumors, Helbig, wearing a Publix T-shirt, explained the unusual position she’s in.
Read More“But I also think there’s a lot of good that comes from talking about the scary and absurdly dark human things that unknowingly connect us.”
View this post on Instagram
Helbig became one of YouTube’s earliest stars with her vlog series “DailyGrace,” later hosting E!’s “The Grace Helbig Show” and co-hosting the podcast “This Might Get Weird” with longtime collaborator Mamrie Hart.
From Remission to Recurrence
Helbig went public with her breast cancer diagnosis in July 2023, after a lump found during a routine gynecological exam led to a mammogram, ultrasound and biopsy that confirmed stage 2A triple-positive breast cancer. Following treatment, she underwent a lumpectomy in late 2023 and remained in remission for several years.
That changed in October, when Helbig shared that her cancer was back. A trip to the emergency room for numbness in her legs led doctors to discover two tumors in her brain, which were surgically removed on October 14.
One week after surgery, Helbig shared a video of herself walking, writing, “I’m a wobbly wandering woman again.” She said the surgery “went as well as it possibly could” and that radiation would be her next step.
Reflecting on how different this experience felt from her first round of treatment, which included chemotherapy, surgery, radiation and hormone therapy, she said, “This was so compacted in its intensity.”
Expert Resources for Patients With a Brain Tumor
In her latest video, Helbig explained her understanding of how breast cancer can come back years after treatment.
View this post on Instagram
“There is the possibility that microscopic breast cancer cells can break away from the diagnosis site and hide out in other areas of your body long before you get your surgery, whether it’s a lumpectomy or a mastectomy, and then they can just sort of announce themselves whenever they want,” she said.
“Which is why breast cancer is as scary as it is and why when you are in remission, you never quite feel totally … safe or clear.”
She described the fear of recurrence as a “ghost of breast cancer past” that had followed her to every mammogram and MRI, adding that because she had already imagined this scenario, she “wasn’t totally thrown off guard” when it happened.
Helbig’s explanation touches on a common misconception: that removing the tumor, or even the whole breast, guarantees cancer won’t return. Surgeons aim to remove every cancer with clear margins, meaning no cancer cells are found at the edges of the removed tissue. But surgery can’t catch every microscopic cell.
“When you’re doing a mastectomy, you are not removing 100% of the breast cells. You can’t,” Dr. Sharon Rosenbaum Smith, a breast surgeon at Northwell Lenox Hill Hospital in New York City, previously told SurvivorNet. “There can always be a microscopic cell left there, and then that cell decides it wants to turn into a malignancy.”
Cancer can return in two main ways. A local recurrence develops in or near the original site, often from cells left in the breast or chest wall. A distant recurrence, like Helbig’s, happens when cancer cells break away before surgery and travel through the bloodstream or lymph system to other organs, such as the brain, bones, liver or lungs. Once breast cancer spreads to distant organs, it is considered stage 4.
That’s why follow-up care continues long after treatment ends, and why any new symptoms, such as a lump, persistent headaches, numbness or other unexplained changes, should be checked by a doctor promptly.
View this post on Instagram
Helbig then admitted that hearing “stage four” sounds frightening, but said the outlook has changed dramatically.
She explained, “Anytime breast cancer metastasizes, you are automatically bumped into stage four… which sounds very scary. But it’s not. If this were 20 years ago, I think it would be very scary. But science and medicine has advanced in so many ways, now stage four is often treated like a chronic illness.”
She credited fellow metastatic breast cancer advocates, including author Elissa Kalver, for showing her what life with stage 4 disease can look like. “As long as I have known them, they have lived these incredibly sort of full and fulfilling lives,” she said, adding that seeing them “primed me to understand that it is paradoxically possible to live beautiful, relatively normal, whatever normal means, lives with stage four metastatic breast cancer.”
She joked that she now gets to join “their elite group of metastatic badasses.”
New Guidelines Tailor Follow-Up Care to Recurrence Risk
Helbig described feeling a “lingering anxiety” at every mammogram and MRI during her years in remission, a fear many breast cancer survivors share. New guidance aims to make that follow-up care more personalized.
In July 2026, the American Society of Clinical Oncology (ASCO) published updated recommendations in the Journal of Clinical Oncology for monitoring breast cancer patients after they finish their initial treatment.
Developed by an ASCO expert panel led by Dr. Zeina Nahleh, chair of the Department of Hematology-Oncology at Cleveland Clinic Florida, and Dr. Maryam Lustberg, director of the Center for Breast Cancer at Smilow Cancer Hospital and Yale Cancer Center, the guidelines recommend tailoring follow-up schedules to each patient’s risk of recurrence rather than using a one-size-fits-all approach.
Key takeaways include:
- Routine monitoring remains important. Medical history reviews, physical exams and mammograms are still central to follow-up care.
- Some visits can happen virtually. Telehealth may be used for certain appointments when appropriate.
- Higher-risk patients may need closer monitoring. People with cancer remaining after chemotherapy given before surgery, inflammatory breast cancer, certain inherited gene mutations such as BRCA1 or BRCA2, or those on specific combination therapies may benefit from more frequent visits, in some cases every three to six months for up to 10 years.
- Additional tests should be used selectively. Blood tests and imaging beyond routine mammograms are recommended in specific situations rather than for every survivor.
“The goal of [the] risk-stratified approach is to better address the heterogeneity of patients’ needs and account for these differences,” Dr. Nahleh said in a statement. “It also emphasizes utilizing resources more effectively in light of the workforce shortage in oncology and rising health care costs.”
For patients, that means your follow-up plan should reflect your own risk and circumstances. Talk with your oncologist about your recurrence risk and how it shapes your monitoring schedule. These guidelines may also evolve as new evidence emerges, with tools such as circulating tumor DNA blood tests still being studied for their ability to detect recurrence early.
Post Treatment, When a New Stage of Your Journey Begins
After a cancer warrior has made it through treatment and scans reveal no evidence of disease, it’s safe to say remission has been reached.
WATCH: Understanding Maintenance Therapy
According to the National Cancer Institute (NCI), remission is defined as a “decrease in or disappearance of signs and symptoms of cancer.” In general, patients who remain in remission for at least five years are considered to have “no signs of cancer” or “no evidence of disease.”
Physicians often avoid saying someone is “cured” of cancer because some cancer cells can remain in the body and could return years down the road (also called recurrence).
While in remission, cancer survivors need to follow guidance from their care team. The types of follow-up may include undergoing regular scans every few months and taking maintenance therapy, which helps slow disease progression and extends the remission period.
Dr. Sagar Lonial, Chief Medical Officer at the Winship Cancer Institute at Emory University previously explained to SurvivorNet, “The premise of maintenance therapy is that we know there may be a low-level disease that’s still there, either at or below the level of detection with formal testing, and we want to use less intense therapy to try and keep it at bay or further reduce the burden even more.”
It’s not uncommon for cancer survivors to experience heightened levels of anxiety after cancer. This notably appears while receiving regular scans to ensure the cancer has not returned. This type of anxiety (also called scanxiety) is normal, and some helpful tips exist to help deal with it.
“The way that I define anxiety is that it’s an internal question that we simply can’t find the answers to,” Dr. Marianna Strongin, a clinical psychologist and founder of Strong In Therapy, previously told SurvivorNet.
Survivors are encouraged to be open with their feelings, not just to themselves but to people they trust. They are also advised to find an activity they love and can become so immersed in that they forget about anxieties associated with cancer.
Psychiatrist Dr. Samantha Boardman suggests that survivors draw four columns on a sheet of paper. Then, they are asked to write down what they know, what they don’t know, and what they can and cannot control.
“It’s a helpful way to dial down their anxiety. It involves trying to move as many items as possible into what they do know and what they can control,” Dr. Boardman said.
Coping with a Brain Tumor: Managing the Emotional and Psychological Impact
Beyond the medical aspects of facing a brain tumor diagnosis, many patients also find themselves struggling with the emotional and psychological challenges a cancer diagnosis can, and often does, bring. It’s natural to experience feelings of anxiety, sadness, or uncertainty.
Because brain tumor treatment can also cause neurological, cognitive, and behavioral changes that affect daily life, acknowledging these challenges and working with your treatment team to find the right sort of support can help you improve your overall wellbeing.
“It’s very individual, related to a person’s personality, their situation, what’s happening in their life, how they react,” Dr. Howard Colman, a neuro-oncologist at the Huntsman Cancer Institute in Salt Lake City, Utah, previously told SurvivorNet. “And so the appropriate responses and management has to be very individualized to that patient.”
Coping with Glioma: Managing the Emotional and Psychological Impact
After receiving brain tumor diagnosis, it’s common to experience a flood of emotions — shock, disbelief, fear, sadness, or even frustration. You may feel a sense of loss or worry about how the condition will affect your daily life. At the same time, your loved ones may also be struggling as they take on new caregiving roles and provide emotional support.
Feelings of depression and anxiety are particularly common. Many patients grieve changes to their independence, cognitive abilities, or physical function — but it’s important to recognize that there are support tools available.
Questions to Ask Your Doctor
If breast cancer has spread to your brain, or to someone you love, it’s important to talk with your care team about testing the tumor and about treatments that can reach the brain. SurvivorNet’s AI‑powered tool, “My Health Questions,” can also help you better understand your diagnosis, explore treatment options, and prepare meaningful questions for upcoming appointments. Here are a few to consider:
- Will the brain tumor be tested to confirm its hormone receptor and HER2 status? Can it be different from my original breast cancer?
- Since my cancer is HER2-positive, which HER2-targeted therapies are options for me? Do any of them work well against tumors in the brain?
- What type of radiation do you recommend, and what side effects should I expect?
- How often will I need brain MRIs and other scans going forward?
- Is there a clinical trial that would be relevant for me?
Contributing: SurvivorNet Staff
Learn more about SurvivorNet's rigorous medical review process.
